$PRCT
PROCEPT BioRobotics Corp Stock $prct

$prct Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022013074 Filed on May 06, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$14.20M	$10.14M	$7.192M
YoY Change	97.4%	31.37%
Cost Of Revenue	$6.505M	$5.622M	$3.665M
YoY Change	77.49%	-37.34%
Gross Profit	$7.692M	$4.516M	$3.527M
YoY Change	118.09%	-459.84%
Gross Profit Margin	54.18%	44.55%	49.04%
Selling, General & Admin	$18.39M	$16.27M	$10.35M
YoY Change	77.65%	-46.25%
% of Gross Profit	239.01%	360.3%	293.42%
Research & Development	$5.011M	$5.076M	$4.522M
YoY Change	10.81%	-68.81%
% of Gross Profit	65.15%	112.4%	128.21%
Depreciation & Amortization	$758.0K	$763.0K	$915.0K
YoY Change	-17.16%	6.71%
% of Gross Profit	9.85%	16.9%	25.94%
Operating Expenses	$23.40M	$21.35M	$14.87M
YoY Change	57.33%	-54.14%
Operating Profit	-$15.70M	-$16.83M	-$11.34M
YoY Change	38.43%	-64.79%
Interest Expense	$1.421M	-$1.503M	$1.464M
YoY Change	-2.94%	-72.18%
% of Operating Profit
Other Income/Expense, Net	-$59.00K	-$14.00K	-$9.000K
YoY Change	555.56%	-107.57%
Pretax Income	-$17.19M	-$18.35M
YoY Change		-65.39%
Income Tax
% Of Pretax Income
Net Earnings	-$17.19M	-$18.35M	-$12.82M
YoY Change	34.03%	-65.39%	-2.32%
Net Earnings / Revenue	-121.05%	-180.98%	-178.28%
Basic Earnings Per Share	-$0.39		-$2.65
Diluted Earnings Per Share	-$0.39	-$414.3K	-$2.65
COMMON SHARES
Basic Shares Outstanding	43.86M shares	43.50M shares	4.830M shares
Diluted Shares Outstanding	43.86M shares		4.830M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$284.3M	$304.3M
YoY Change
Cash & Equivalents	$284.3M	$304.3M	$86.12M
Short-Term Investments
Other Short-Term Assets	$3.531M	$3.412M
YoY Change
Inventory	$12.63M	$13.15M
Prepaid Expenses
Receivables	$6.992M	$4.464M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$308.0M	$326.2M
YoY Change		195.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.560M	$5.045M
YoY Change		-39.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.814M	$0.00
YoY Change
Total Long-Term Assets	$12.93M	$10.85M
YoY Change		-30.95%
TOTAL ASSETS
Total Short-Term Assets	$308.0M	$326.2M
Total Long-Term Assets	$12.93M	$10.85M
Total Assets	$320.9M	$337.0M
YoY Change		167.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.628M	$2.029M
YoY Change		63.63%
Accrued Expenses	$8.615M	$11.21M
YoY Change
Deferred Revenue	$1.368M	$1.025M
YoY Change		339.91%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$14.76M	$16.24M
YoY Change		11.81%
LONG-TERM LIABILITIES
Long-Term Debt	$50.25M	$50.00M
YoY Change		12.6%
Other Long-Term Liabilities	$200.0K	$200.0K
YoY Change		0.0%
Total Long-Term Liabilities	$50.45M	$50.20M
YoY Change		12.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.76M	$16.24M
Total Long-Term Liabilities	$50.45M	$50.20M
Total Liabilities	$68.16M	$69.93M
YoY Change		7.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$278.7M	-$261.5M
YoY Change		29.68%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$252.8M	$267.1M	-$193.9M
YoY Change
Total Liabilities & Shareholders Equity	$320.9M	$337.0M
YoY Change		167.54%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$17.19M	-$18.35M	-$12.82M
YoY Change	34.03%	-65.39%	-2.32%
Depreciation, Depletion And Amortization	$758.0K	$763.0K	$915.0K
YoY Change	-17.16%	6.71%
Cash From Operating Activities	-$18.23M	-$16.48M	-$15.20M
YoY Change	19.96%	22.54%
INVESTING ACTIVITIES
Capital Expenditures	$55.00K	-$332.0K	$39.00K
YoY Change	41.03%	3588.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$55.00K	-$332.0K	-$39.00K
YoY Change	41.03%	3588.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.291M	644.0K	$1.225M
YoY Change	5.39%	171.73%
NET CHANGE
Cash From Operating Activities	-$18.23M	-16.48M	-$15.20M
Cash From Investing Activities	-$55.00K	-332.0K	-$39.00K
Cash From Financing Activities	$1.291M	644.0K	$1.225M
Net Change In Cash	-$17.00M	-16.16M	-$14.01M
YoY Change	21.29%	22.3%
FREE CASH FLOW
Cash From Operating Activities	-$18.23M	-$16.48M	-$15.20M
Capital Expenditures	$55.00K	-$332.0K	$39.00K
Free Cash Flow	-$18.29M	-$16.14M	-$15.24M
YoY Change	20.01%	20.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001588978
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	PROCEPT BioRobotics Corporation
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40797
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0199180
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Island Drive
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94065
CY2022Q1	dei	City Area Code CityAreaCode	650
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	232-7200
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	PRCT
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44173322	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	284288000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304320000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6992000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4464000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	12629000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	13147000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4070000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4242000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	307979000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	326173000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3814000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	777000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4560000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5045000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2877000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6475000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1368000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3279000	USD
CY2022Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1682000	USD
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1750000	USD
CY2022Q1	us-gaap	Assets Assets	320912000	USD
CY2021Q4	us-gaap	Assets Assets	337024000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2628000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2029000	USD
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4586000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1025000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2181000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2105000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3994000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4608000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14757000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16242000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50254000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50004000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1418000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1991000	USD
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1533000	USD
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1496000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	68162000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	69933000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44077000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44077000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43676000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43676000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	531509000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	528666000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-53000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-278706000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261521000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	252750000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	320912000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337024000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14197000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7192000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	6505000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	3665000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	7692000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15704000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	3527000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5011000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4522000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18385000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10349000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	23396000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	14871000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11344000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	1421000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1464000	USD
CY2022Q1	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	-60000	USD
CY2021Q1	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	-14000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.65
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.65
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43855000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43855000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4830000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4830000	shares
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-16000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17184000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12838000	USD
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1291000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1552000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	USD
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	252750000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-182894000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1225000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	650000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-16000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-193857000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2529000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	758000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	915000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1552000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	650000	USD
CY2022Q1	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	37000	USD
CY2021Q1	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	-280000	USD
CY2022Q1	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	97000	USD
CY2021Q1	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	79000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2584000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-517000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	926000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-177000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	420000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	448000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	701000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-1889000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-815000	USD
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	250000	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-92000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	343000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	173000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-613000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	381000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18231000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15198000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1291000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1225000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	288102000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1291000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1225000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16995000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14012000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305097000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100907000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86895000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	284288000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86118000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3814000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	777000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	288102000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86895000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1171000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1171000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261500000	USD
CY2022Q1	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	0	USD
CY2021Q1	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	-190000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	351000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	284300000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304300000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-278700000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company’s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, the valuations of the redeemable convertible preferred stock warrant liability and </span></div>loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents and, to a lesser extent, accounts receivable. The Company believes that credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and diversity of its customer base. The Company generally does not require collateral and losses on accounts receivable have historically been within management’s expectations. </span></div>The Company’s investment policy limits investments to certain types of debt securities issued by the U.S. government, its agencies, and institutions with investment-grade credit ratings, as well as corporate debt or commercial paper issued by the highest quality financial and non-financial companies, and places restrictions on maturities and concentration by type and issuer. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash and cash equivalents and issuers of investments to the extent recorded on the balance sheets. The Company has limited its credit risk associated with cash and cash equivalents by placing its investments with banks it believes are highly creditworthy and with highly rated investments.
CY2021Q3	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	13200000	USD
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2900000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q1	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	Impairment of Long-Lived Assets Long-lived assets consist primarily of property and equipment and intangible assets, net, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require that a long-lived asset be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated by the asset group to the carrying amount of the asset group. If the carrying amount of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying amount exceeds its fair value. The Company determines fair value using the income approach based on the present value of expected future cash flows or other appropriate measures of estimated fair value. The Company’s cash flow assumptions consider historical and forecasted revenue and operating costs and other relevant factors. During the three months ended March 31, 2022 and 2021, the Company has not recorded impairment charges on its long-lived assets.
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q1	prct	Product Warranty Term ProductWarrantyTerm	P1Y
CY2022Q1	prct	Service Agreement Amortization Period ServiceAgreementAmortizationPeriod	P1Y
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14197000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7192000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43855000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43855000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4830000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4830000	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.65
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.65
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6414000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31919000	shares
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5401000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6740000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	323000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	905000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6905000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5502000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	12629000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	13147000	USD
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1901000	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2333000	USD
CY2022Q1	prct	Prepaid Inventory PrepaidInventory	539000	USD
CY2021Q4	prct	Prepaid Inventory PrepaidInventory	830000	USD
CY2022Q1	prct	Prepaid Software PrepaidSoftware	683000	USD
CY2021Q4	prct	Prepaid Software PrepaidSoftware	428000	USD
CY2022Q1	us-gaap	Prepaid Rent PrepaidRent	252000	USD
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	253000	USD
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	695000	USD
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	398000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4070000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4242000	USD
CY2021Q4	prct	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	741000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	542000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	600000	USD
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	684000	USD
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	515000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11846000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11739000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7286000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6694000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4560000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5045000	USD
CY2022Q1	prct	Accrued Purchases AccruedPurchases	219000	USD
CY2021Q4	prct	Accrued Purchases AccruedPurchases	1105000	USD
CY2022Q1	prct	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	1035000	USD
CY2021Q4	prct	Finite Lived Intangible Asset Expected Annual Amortization Expense FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense	300000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	403000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	405000	USD
CY2022Q1	prct	Accrued Travel Expenses Current AccruedTravelExpensesCurrent	305000	USD
CY2021Q4	prct	Accrued Travel Expenses Current AccruedTravelExpensesCurrent	281000	USD
CY2022Q1	prct	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	127000	USD
CY2021Q4	prct	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	183000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	679000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	778000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3994000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4608000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	36000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	14000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-24000	USD
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-37000	USD
CY2021Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-43000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	USD
CY2022Q1	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	-60000	USD
CY2021Q1	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	-14000	USD
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2500000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	900000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	800000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	53900000	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	54500000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	26983984	shares
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402402	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	94600000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	64300000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	172400000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	125700000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8700000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1500000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1000000	USD
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1100000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1552000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	650000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	18700000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	10600000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1842000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	1842000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2092000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12500000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	14592000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	37500000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	37500000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3934000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	53934000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	335000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	254000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	81000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1418000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2445000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	37500000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3599000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	50254000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	53853000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2181000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	2181000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50254000	USD
CY2022Q1	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	51672000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	2445000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2092000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	12500000	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	14592000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	37500000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4537000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	54537000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	441000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	4000	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	437000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4096000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	50004000	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	54100000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2105000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	2105000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1991000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	50004000	USD
CY2021Q4	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	51995000	USD

Files In Submission

Name	View Source	Status
0001628280-22-013074-index-headers.html	Edgar Link	pending
0001628280-22-013074-index.html	Edgar Link	pending
0001628280-22-013074.txt	Edgar Link	pending
0001628280-22-013074-xbrl.zip	Edgar Link	pending
ex311soxcertificationrzadn.htm	Edgar Link	pending
ex312soxcertificationkwate.htm	Edgar Link	pending
ex321soxcertificationrzadn.htm	Edgar Link	pending
ex322soxcertificationkwate.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prct-20220331.htm	Edgar Link	pending
prct-20220331.xsd	Edgar Link	pending
prct-20220331_cal.xml	Edgar Link	unprocessable
prct-20220331_def.xml	Edgar Link	unprocessable
prct-20220331_htm.xml	Edgar Link	completed
prct-20220331_lab.xml	Edgar Link	unprocessable
prct-20220331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRCT
PROCEPT BioRobotics Corp Stock $prct

2022 Q1 Form 10-Q Financial Statement

#000162828022013074 Filed on May 06, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT PROCEPT BioRobotics Corp Stock $prct

2022 Q1 Form 10-Q Financial Statement

#000162828022013074 Filed on May 06, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT
PROCEPT BioRobotics Corp Stock $prct